Clinical Trial Update: Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex

View source ↗

Summary

A completed clinical trial update investigating the genetic basis of primary pigmented nodular adrenocortical disease (PPNAD) and the Carney complex.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carney Complex
• Cushing Syndrome
• Peutz-jeghers Syndrome
• Pigmented Nodular Adrenocortical Disease
• Pituitary Adenoma

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Cushing's Syndrome, Pituitary Adenoma | Status: COMPLETED